• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用天然I型胶原蛋白基质加聚六亚甲基双胍治疗慢性伤口

Use of Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide for Chronic Wound Treatment.

作者信息

Oropallo Alisha R

机构信息

Department of Surgery, Northwell Health, Lake Success, N.Y.

Department of Transplantation, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Hempstead, N.Y.

出版信息

Plast Reconstr Surg Glob Open. 2019 Jan 15;7(1):e2047. doi: 10.1097/GOX.0000000000002047. eCollection 2019 Jan.

DOI:10.1097/GOX.0000000000002047
PMID:30859031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6382242/
Abstract

BACKGROUND

Chronic wounds represent a significant financial burden to the healthcare system and a quality-of-life burden to patients. Many chronic wounds have elevated bioburden in the form of biofilm, which has been associated with delayed wound healing. This study examined the use of a native type I collagen matrix with the antimicrobial polyhexamethylene biguanide (PCMP) in the management of bioburden and treatment of chronic, nonhealing wounds over 12 weeks.

METHODS

A prospective case series of PCMP enrolled adults ≥18 years old with a nonhealing wound. At week 0, the wound was prepared by sharp or mechanical debridement. Patients received standard wound care plus PCMP applications at week 0 and then weekly up to week 12 at the investigator's discretion. Dressings were applied over PCMP to fix it in place. At each visit, wounds were assessed for the extent of healing and signs of wound infection.

RESULTS

Of the 41 wounds studied, 44% were pressure ulcers, 22% were surgical wounds, 12% were venous ulcers, 10% were diabetic ulcers, and 12% were another type. The median (interquartile range) baseline wound area was 7.2 (14.9) cm, and the mean wound duration was 103 weeks. Of the 41 wounds, 73% demonstrated a reduction in wound area at 12 weeks, and 37% achieved complete wound closure, with a mean time of 6.7 weeks to complete closure.

CONCLUSION

PCMP treatment appeared to positively impact the course of wound healing in a variety of complex, chronic wounds that were unresponsive to prior treatment.

摘要

背景

慢性伤口给医疗系统带来了巨大的经济负担,也给患者的生活质量造成了负担。许多慢性伤口以生物膜的形式存在生物负荷升高的情况,这与伤口愈合延迟有关。本研究在12周内检查了天然I型胶原蛋白基质与抗菌剂聚六亚甲基双胍(PCMP)在管理生物负荷和治疗慢性不愈合伤口方面的应用。

方法

一项前瞻性病例系列研究,纳入了年龄≥18岁的患有不愈合伤口的成年人。在第0周,通过锐性或机械清创术对伤口进行处理。患者在第0周接受标准伤口护理并应用PCMP,然后由研究者自行决定每周应用一次,直至第12周。在PCMP上覆盖敷料以固定其位置。每次就诊时,评估伤口的愈合程度和伤口感染迹象。

结果

在研究的41处伤口中,44%为压疮,22%为手术伤口,12%为静脉溃疡,10%为糖尿病溃疡,12%为其他类型。基线伤口面积的中位数(四分位间距)为7.2(14.9)平方厘米,平均伤口持续时间为103周。在41处伤口中,73%在12周时伤口面积减小,37%实现了伤口完全闭合,完全闭合的平均时间为6.7周。

结论

PCMP治疗似乎对多种先前治疗无反应的复杂慢性伤口的愈合过程产生了积极影响。

相似文献

1
Use of Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide for Chronic Wound Treatment.使用天然I型胶原蛋白基质加聚六亚甲基双胍治疗慢性伤口
Plast Reconstr Surg Glob Open. 2019 Jan 15;7(1):e2047. doi: 10.1097/GOX.0000000000002047. eCollection 2019 Jan.
2
Effect of Native Type I Collagen with Polyhexamethylene Biguanide Antimicrobial on Wounds: Interim Registry Results.天然I型胶原蛋白与聚六亚甲基双胍抗菌剂对伤口的影响:中期注册结果
Plast Reconstr Surg Glob Open. 2019 Jun 12;7(6):e2251. doi: 10.1097/GOX.0000000000002251. eCollection 2019 Jun.
3
Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series.一种含聚六亚甲基双胍的新型纯化胶原蛋白基质对各种病因顽固性伤口的影响:病例系列研究
Wounds. 2018 Mar;30(3):72-78.
4
Effectiveness of type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of pressure injuries.I型胶原基质加聚六亚甲基双胍抗菌剂治疗压疮的有效性
Wounds. 2022 Jun;34(6):159-164. doi: 10.25270/wnds/2022.159164.
5
Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds.I 型胶原蛋白基质加聚六亚甲基双胍抗菌剂治疗皮肤创伤。
J Comp Eff Res. 2020 Jul;9(10):691-703. doi: 10.2217/cer-2020-0058. Epub 2020 Jun 1.
6
A Prospective Noninterventional Study of Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial for the Treatment of Venous Leg Ulcers: A Secondary Analysis.一项关于 I 型胶原蛋白基质加聚六亚甲基双胍抗菌剂治疗静脉溃疡的前瞻性非干预性研究:二次分析。
Wound Manag Prev. 2022 Jun;68(6):11-17.
7
A single-center pilot study investigating the effects of a native cross-linked extracellular matrix with polyhexamethylene biguanide to manage chronic lower extremity wounds exhibiting bacterial contamination.一项单中心试点研究,旨在调查具有聚六亚甲基双胍的天然交联细胞外基质对表现出细菌污染的慢性下肢伤口的管理效果。
Wound Manag Prev. 2023 May;69(2):5-13.
8
Efficacy of the Application of a Purified Native Collagen With Embedded Antimicrobial Barrier Followed by a Placental Allograft on a Diverse Group of Nonhealing Wounds of Various Etiologies.应用一种嵌入抗菌屏障的纯化天然胶原蛋白并随后进行胎盘同种异体移植对不同病因的多种难愈合伤口的疗效。
Wounds. 2021 Jan;33(1):20-27. doi: 10.25270/wnds/2021.2027.
9
Effectiveness of a purified type I collagen matrix plus the antimicrobial polyhexamethylene biguanide for use in cutaneous wounds: analysis of a population of three combined registries.一种纯化 I 型胶原蛋白基质联合聚六亚甲基双胍的抗菌剂在皮肤创伤中的疗效:三个联合注册研究人群分析。
Wounds. 2023 Sep;35(9):E290-E296. doi: 10.25270/wnds/20174.
10
Real-World Comparative Effectiveness Assessment Study of a Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial and a Cryopreserved Cadaveric Skin Allograft for Use in Diabetic Foot Ulcers - A Non-inferiority Analysis.用于糖尿病足溃疡的天然I型胶原基质加聚六亚甲基双胍抗菌剂与冷冻保存的尸体皮肤同种异体移植物的真实世界比较有效性评估研究——一项非劣效性分析。
Eplasty. 2024 Apr 4;24:e16. eCollection 2024.

引用本文的文献

1
Varying Properties of Extracellular Matrix Grafts Impact Their Durability and Cell Attachment and Proliferation in an Chronic Wound Model.细胞外基质移植物的不同特性影响其在慢性伤口模型中的耐久性以及细胞附着和增殖。
J Tissue Eng Regen Med. 2024 Apr 26;2024:6632276. doi: 10.1155/2024/6632276. eCollection 2024.
2
Real-World Comparative Effectiveness Assessment Study of a Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial and a Cryopreserved Cadaveric Skin Allograft for Use in Diabetic Foot Ulcers - A Non-inferiority Analysis.用于糖尿病足溃疡的天然I型胶原基质加聚六亚甲基双胍抗菌剂与冷冻保存的尸体皮肤同种异体移植物的真实世界比较有效性评估研究——一项非劣效性分析。
Eplasty. 2024 Apr 4;24:e16. eCollection 2024.
3

本文引用的文献

1
Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series.一种含聚六亚甲基双胍的新型纯化胶原蛋白基质对各种病因顽固性伤口的影响:病例系列研究
Wounds. 2018 Mar;30(3):72-78.
2
Clinic-based Debridement of Chronic Ulcers Has Minimal Impact on Bacteria.基于临床的慢性溃疡清创术对细菌影响极小。
Wounds. 2018 May;30(5):114-119. Epub 2018 Feb 23.
3
An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds.慢性难愈合伤口的影响、成本及医疗保险政策影响的经济评估
Updates on Recent Clinical Assessment of Commercial Chronic Wound Care Products.
最新商业慢性伤口护理产品临床评估进展。
Adv Healthc Mater. 2023 Oct;12(25):e2300556. doi: 10.1002/adhm.202300556. Epub 2023 Jul 23.
4
Use of Local Antibiotic Delivery Systems in Tissue Expander and Implant-Based Breast Reconstruction: A Systematic Review of the Literature.局部抗生素递送系统在组织扩张器和植入物乳房重建中的应用:文献系统评价
Eplasty. 2023 Apr 12;23:e24. eCollection 2023.
5
Surgical Reconstruction of Stage 3 and 4 Pressure Injuries: A Literature Review and Proposed Algorithm from an Interprofessional Working Group.外科重建 3 期和 4 期压力性损伤:来自跨专业工作组的文献综述和建议算法。
Adv Skin Wound Care. 2023 May 1;36(5):249-258. doi: 10.1097/01.ASW.0000922708.95424.88.
6
Venous leg ulcers treated with fish collagen gel in a 12-week randomized single-centre study.在一项为期12周的单中心随机研究中,用鱼胶原蛋白凝胶治疗腿部静脉溃疡。
Postepy Dermatol Alergol. 2022 Aug;39(4):714-722. doi: 10.5114/ada.2021.108424. Epub 2021 Aug 16.
7
Extracellular Vesicles as Therapeutic Tools for the Treatment of Chronic Wounds.细胞外囊泡作为治疗慢性伤口的治疗工具
Pharmaceutics. 2021 Sep 23;13(10):1543. doi: 10.3390/pharmaceutics13101543.
8
Alternative Approaches for the Management of Diabetic Foot Ulcers.糖尿病足溃疡管理的替代方法。
Front Microbiol. 2021 Oct 5;12:747618. doi: 10.3389/fmicb.2021.747618. eCollection 2021.
9
Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide.含聚六亚甲基双胍天然细胞外基质的创伤基质的抗菌效果。
Int Wound J. 2022 Jan;19(1):86-99. doi: 10.1111/iwj.13600. Epub 2021 May 6.
10
Antibacterial-Integrated Collagen Wound Dressing for Diabetes-Related Foot Ulcers: An Evidence-Based Review of Clinical Studies.用于糖尿病相关足部溃疡的抗菌整合型胶原蛋白伤口敷料:临床研究的循证综述
Polymers (Basel). 2020 Sep 22;12(9):2168. doi: 10.3390/polym12092168.
Value Health. 2018 Jan;21(1):27-32. doi: 10.1016/j.jval.2017.07.007. Epub 2017 Sep 19.
4
Consensus on Wound Antisepsis: Update 2018.伤口消毒共识:2018年更新
Skin Pharmacol Physiol. 2018;31(1):28-58. doi: 10.1159/000481545. Epub 2017 Dec 21.
5
Proactive and Early Aggressive Wound Management: A Shift in Strategy Developed by a Consensus Panel Examining the Current Science, Prevention, and Management of Acute and Chronic Wounds.
Wounds. 2017 Nov;29(11):S37-S42.
6
IDF Clinical Practice Recommendation on the Diabetic Foot: A guide for healthcare professionals.国际糖尿病联盟糖尿病足临床实践建议:医护人员指南
Diabetes Res Clin Pract. 2017 May;127:285-287. doi: 10.1016/j.diabres.2017.04.013. Epub 2017 Apr 9.
7
The Effectiveness of Topical Polyhexamethylene Biguanide (PHMB) Agents for the Treatment of Chronic Wounds: A Systematic Review.外用聚六亚甲基双胍(PHMB)制剂治疗慢性伤口的有效性:一项系统评价。
Surg Technol Int. 2016 Oct 26;29:45-51.
8
Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.感染性糖尿病足溃疡对住院及费用的负担
Ann Vasc Surg. 2016 May;33:149-58. doi: 10.1016/j.avsg.2015.11.025. Epub 2016 Feb 22.
9
Venous ulcers of the lower extremity: Definition, epidemiology, and economic and social burdens.下肢静脉溃疡:定义、流行病学以及经济和社会负担。
Semin Vasc Surg. 2015 Mar;28(1):3-5. doi: 10.1053/j.semvascsurg.2015.05.002. Epub 2015 May 8.
10
Cellular and molecular mechanisms of repair in acute and chronic wound healing.急性和慢性伤口愈合中的修复细胞与分子机制。
Br J Dermatol. 2015 Aug;173(2):370-8. doi: 10.1111/bjd.13954. Epub 2015 Jul 14.